ArticleMolecular and clinical oncology2019

Targeted therapy with trastuzumab for epidermal growth factor receptor 2 (HER2)-positive advanced salivary duct carcinoma: A case report.

Takahiko Gibo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.